(Reuters) - Escalon's Trilogy device measures glucose, creatinine and
urea nitrogen in serum. These measurements are used in the
diagnosis of various kidney and metabolic diseases such as
diabetes, the tiny medical devices company said.
The Wayne, Pennsylvania-based firm's shares rose $2.50 to
$8.40 in afternoon trade on the Nasdaq.
Read more at Reuters.com Government Filings News
urea nitrogen in serum. These measurements are used in the
diagnosis of various kidney and metabolic diseases such as
diabetes, the tiny medical devices company said.
The Wayne, Pennsylvania-based firm's shares rose $2.50 to
$8.40 in afternoon trade on the Nasdaq.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment